EMEA-002183-PIP01-17-M01

Table of contents

Key facts

Invented name
Idefirix
Active substance
Imlifidase
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0076/2022
PIP number
EMEA-002183-PIP01-17-M01
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Prevention of graft rejection following solid organ transplantation
Route(s) of administration
Intravenous use
Contact for public enquiries
Hansa Biopharma AB

E-mail: info@hansabiopharma.com
Tel: +46 46165670

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating